More than half of bladder cancers in the US are the result of smoking, and 90 per cent of smokers with the disease are aware of the connection, according to a new study.
"Bladder cancer is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim.
Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found…
Stories
Brittany Maynard, the terminally ill cancer patient whose viral YouTube video reignited the debate on assisted-suicide, ended her life on Saturday. Bioethicist Arthur L Caplan says that Ms Maynard's story has the potential to change the way many people - particularly younger Americans - view the issue. "I am terrified to think that my children will grow up in a culture that openly venerates suicide with this much unyielding passion” "A whole new generation is now looking at Brittany…
Inflammation has been linked to a slew of diseases – from allergies to cancer, heart trouble, bowel problems and diabetes. What is it and how can we protect ourselves. - By paediatrician and family practitioner Dr Gita Mathai. What is inflammation? The word is derived from the Latin “inflammo” meaning ignite or set alight. It conjures up visions of fire, and it is the body’s response to an injury, like a broken bone, a scrape in the skin or an infection by an organism (…
Cancer Institute chairperson Dr V Shanta expressed concern over underreporting of cancer among children, especially in rural areas. Advances in oncology over the past six decades have ensured that up to 75 % of all paediatric cancers can be cured. While it is possible to treat all pediatric cases in the country, there is a need to increase affordability and accessibility for the same," she said. http://timesofindia.indiatimes.com/City/Chennai/Parents-deny-girls-cancer-treatment-say-doctors…
Do not fear Chemotherapy ! Understand Chemotherapy and how to deal with it. A great video in Hindi by SanjeevaniLifeBeyondCancer
Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
"I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
My cancer could have been caught earlier if I had been alerted about spotting between periods, heavy periods and watery blood between periods as the main symptoms of womb cancer,” she says. But when she asked NHS Choices whether there should be mention of womb cancer on the menopause pages, she received the following reply: “The problem with adding a warning about womb cancer to the menopause pages is that it may cause unnecessary panic.” And this, says Widschwendter, is the nub of the problem…
The FDA initially approved XTANDI, an oral, once-daily androgen receptor inhibitor, in August 2012 for use in patients with metastatic CRPC who previously received docetaxel (chemotherapy). The new indication approves XTANDI for use in men with metastatic CRPC who have not received chemotherapy. Metastatic CRPC is defined as a cancer that has spread beyond the prostate gland and has progressed despite treatment to lower testosterone (i.e., with a gonadotropin-releasing hormone (GnRH) therapy or…
